RCEL

$16.07+4.83%visit website

AVITA Medical, Inc.

Market Cap

$497M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

2.01

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

6.6

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	17,062	17,615	19,251	21,702	75,630
Cost of revenue	3,187	3,304	3,523	3,935	13,949
Gross profit	13,875	14,311	15,728	17,767	61,681
Research & development	3,748	5,691	5,629	5,078	20,146
Total operating expenses	23,028	24,719	24,531	24,622	96,900
Operating income	(9,153)	(10,408)	(8,803)	(6,855)	(35,219)
Interest expense	1,268	1,250	1,424	1,463	5,405
Pretax income	(13,172)	(11,638)	(10,622)	(7,630)	(43,062)
Income tax	15.0	(17.0)	(11.0)	33.0	20.0
Net income	(13,187)	(11,621)	(10,611)	(7,663)	(43,082)
EPS (basic) ($)	(0.46)		(0.35)	(0.25)	(1.44)
EPS (diluted) ($)	(0.46)		(0.35)	(0.25)	(1.44)
Weighted avg. shares (basic)	28,393		30,541	30,750
Weighted avg. shares (diluted)	28,393		30,541	30,750

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 28 more quarters, back to Sep 2018, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 4:32 PM ET	7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

60%

W/W -13.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-09	2026-06-10	Woody Joseph Fralin	Director	Purchase	5,200	$4.00	$21K	108.0K	View
2026-06-03	2026-06-05	Woody Joseph Fralin	Director	Purchase	5,000	$4.10	$20K	87.8K	View
2026-06-02	2026-06-03	Woody Joseph Fralin	Director	Purchase	5,000	$4.18	$21K	15.0K	View
2026-06-01	2026-06-03	Woody Joseph Fralin	Director	Purchase	5,000	$4.34	$22K	5,000	View
2026-05-20	2026-05-20	O'Toole David D	CFO	Purchase	2,000	$4.26	$9K	145.9K	View